Opko Health Stock Rises on $722M BioReference Asset Sale to Labcorp

Key Facts

1Opko Health shares surged following the announcement of a deal to sell select assets from its BioReference Health unit.

2The transaction with Labcorp is valued at approximately $722 million.

Opko Health shares surged following the announcement of a deal to sell select assets from its BioReference Health unit. Investing.com reported that the transaction with Labcorp is valued at approximately $722 million, involving the divestment of specific laboratory business assets.

OPK closed at $1.37 on October 14, 2026, after reaching a day high of $1.37 and a low of $1.30. The market reacted positively to the strategic divestment and the resulting cash infusion from a major industry player like Labcorp.